Delivery Order SPE2DB22D3004-SPE2DB24FQD84
Award Date 4/29/24
Potential Completion Date 4/30/24
Potential Value $1.9K
Federal Agency
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the supply of the pharmaceutical product WEGOVY 2.4 MG/0.75 ML PEN 0.75ML to the Defense Logistics Agency (DLA). The firm-fixed-price delivery order, valued at $1,097.08, has an ultimate completion date of April 24, 2024. Amerisourcebergen holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical as the primary vehicle for delivering a comprehensive range of...
- This federal contract award to Amerisourcebergen Drug Corp's Corporate Office division is for the delivery of the pharmaceutical product WEGOVY 0.25 MG/0.5 ML PEN 0.5ML. The single-award Indefinite Delivery Contract (IDC), valued up to $999,999,999.00, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen as the prime contractor. This IDC serves as the primary vehicle for Amerisourcebergen to provide a comprehensive range of pharmaceutical products and...
- This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of the pharmaceutical product WEGOVY 0.5 MG/0.5 ML PEN 0.5ML. The award is a Delivery Order with a Firm Fixed Price of $2,171.78, with an ultimate completion date of April 23, 2024. The contracting agency is the Defense Logistics Agency (DLA), which is a defense agency supporting the U.S. Armed Forces and other government agencies. Amerisourcebergen holds a larger Indefinite Delivery...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, is a delivery order valued at $4,975.31 for the pharmaceutical product WEGOVY 1 MG/0.5 ML PEN 0.5ML. The contract was awarded by the Defense Logistics Agency (DLA) Troop Support Medical, a component of the U.S. Department of Defense. This delivery order is part of a larger indefinite delivery contract (IDC) held by Amerisourcebergen Drug Corp, valued up to $999,999,999.00, that serves as...
- This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the supply of the pharmaceutical product WEGOVY 1 MG/0.5 ML PEN 0.5ML. The $2,967.13 firm fixed price delivery order was issued by the Defense Logistics Agency (DLA), a defense agency that provides logistics, acquisition, and technical services to the U.S. Armed Forces and other government agencies. The award is part of a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA...
- This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the supply of the pharmaceutical product WEGOVY 0.5 MG/0.5 ML PEN 0.5ML. The award, valued at $1,097.08, is a delivery order placed under Amerisourcebergen's Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support Medical. This single-award IDC, valued up to $999,999,999.00 through December 31, 2025, serves as the primary vehicle for Amerisourcebergen to provide a wide...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, is a delivery order from the Defense Logistics Agency (DLA) for the pharmaceutical product WEGOVY 0.5 MG/0.5 ML PEN 0.5ML. The $1,097.08 firm fixed price contract has a completion date of March 5, 2024. Amerisourcebergen Drug Corp serves as a prime contractor to the DLA Troop Support Medical program, providing a range of pharmaceutical and medical products and services to U.S. Department of...
- This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the pharmaceutical product WEGOVY 1 MG/0.5 ML PEN 0.5ML. The $1,097.08 firm fixed-price delivery order was issued by the Defense Logistics Agency (DLA), a defense agency, with a completion date of June 7, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 through December 31, 2025, which serves as the primary vehicle for Amerisourcebergen to deliver a...
- This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the supply of the prescription medication WEGOVY 0.5 MG/0.5 ML PEN 0.5ML. The contract, awarded by the Defense Logistics Agency (DLA), has a ceiling value of $2,942.47 and is a Firm Fixed Price Delivery Order. The contract has an ultimate completion date of May 30, 2024. Amerisourcebergen, a major pharmaceutical distribution company, has an extensive Indefinite Delivery Contract (IDC) with the DLA Troop...
- This federal contract award to Amerisourcebergen Drug Corp is a Delivery Order valued at $22,343.76 for the pharmaceutical product "WEGOVY 0.5 MG/0.5 ML PEN 0.5ML". The award was made by the Defense Logistics Agency (DLA), a defense agency, and has an ultimate completion date of April 30, 2024. This Delivery Order is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, valued at $999,999,999 and running through November...
- SPE2DB22D3004Indefinite Delivery Contract
- SPE2DB22D3004-SPE2DB24FQD84Delivery Order
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the supply of the pharmaceutical product WEGOVY 1 MG/0.5 ML PEN 0.5ML to the Defense Logistics Agency (DLA). The contract, valued at $1,908.62, is a delivery order issued under Amerisourcebergen's Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which is a single-award IDC valued up to $999,999,999.00 through December 31, 2025. This IDC serves as the primary vehicle for Amerisourcebergen to provide a comprehensive range of pharmaceutical products and medical supplies to DLA facilities supporting the Department of Defense (DoD) worldwide. The contract does not have a set-aside designation.
Generated 7/29/24, 9:08 AM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.9k | 4/29/24 |